KRAS and lung carcinoma: LKB1 inactivation in KRAS mutant lung cancer cells promotes glutaminolysis and facilitates the formation of glutamine-derived succinate, fumarate and malate in the later stages of TCA cycle, thus promoting mitochondrial oxidative phosphorylation (Caiola et al., 2018).